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Objectives. Comparisons of cancer
survival in Canadian and US metropol-
itan areas have shown consistent Cana-
dian advantages. This study tests a health
insurance hypothesis by comparing can-
cer survival in Toronto, Ontario, and
Honolulu, Hawaii.
Methods. Ontario and Hawaii reg-
istries provided a total of 9190 and 2895
cancer cases (breast and prostate, 1986–
1990, followed until 1996). Socioeco-
nomic data for each person’s residence at
the time of diagnosis were taken from
population censuses.
Results. Socioeconomic status and
cancer survival were directly associated
in the US cohort, but not in the Cana-
dian cohort. Compared with similar pa-
tients in Honolulu, residents of low-
income areas in Toronto experienced
5-year survival advantages for breast and
prostate cancer. In support of the health
insurance hypothesis, between-country
differences were smaller than those ob-
served with other state samples and the
Canadian advantage was larger among
younger women.
Conclusions. Hawaii seems to pro-
vide better cancer care than many other
states, but patients in Toronto still enjoy
a significant survival advantage. Al-
though Hawaii’s employer-mandated
health insurance coverage seems an ef-
fective step toward providing equitable
health care, even better care could be ex-
pected with a universally accessible,
single-payer system. (Am J Public
Health. 2000;90:1866–1872)
A recent study of cancer survival in
Toronto, Ontario, and in Detroit, Michigan,
compared their ecologically defined poor and
found advantaged survival among Canadians
for 13 of 15 cancer sites (weighted mean 5-
year survival rate ratio [SRR]=1.55).1,2 This
consistent pattern of Canadian cancer survival
advantage was then systematically replicated
with 3 more economically resourceful US met-
ropolitan areas (Seattle, Wash; San Francisco,
Calif; and Hartford, Conn).3 Again, signifi-
cantly better 5-year survival rates were ob-
served for 13 of 15 common types of cancer
among the relatively poor of Toronto compared
with similarly poor US subjects (SRR=1.35).
Moreover, no such between-country differen-
tials were observed in the middle- or high-
income groups. Cancer survival reported in the
first Canada–US comparative study in this re-
search field was substantively similar.4 How-
ever, that study’s essentially nonsignificant
findings are not surprising, as it did not include
any measure of socioeconomic status (SES).
It merely compared cohorts across all aggre-
gated SES levels and so could not observe any
modification of between-country survival dif-
ferences by SES.
Another recent study, which systemati-
cally replicated Canadian cancer survival ad-
vantages among those who live in relatively
poor communities, probably compromised in-
ternal validity in its attempt to extend external
validity.5 Its aggregate comparison of the
province of Ontario with a sample of the entire
United States may have been confounded by
other than socioeconomic variability related to
the diverse metropolitan, exurban, and rural
residences represented among its samples or,
relatedly, by the size of its ecologic units of
analysis, which ranged by a factor of more than
1000, from smaller areal units (e.g., census
tract, 0.5 km2) typical of metropolitan areas to
much larger census subdivision or county units
(e.g., 500 km2) more typically used in other
areas. The present study attempts to extend this
research field’s external validity without mak-
ing such compromises.
The central inference has been that a key
structural difference between Canada and the
United States—single-payer vs multipayer
health care systems—is the most cogent ex-
planation for the observed consistent pattern
of Canadian survival advantage across various
cancer sites; that is, the more equitable access
they offer to preventive and therapeutic health
care services is responsible for the differences.
In the United States, insurance status—nonin-
sured or underinsured vs some insurance or
better insured—has been found to be strongly
associated with the receipt of primary care, the
receipt of cancer screening services, stage of
cancer at the time of diagnosis,6–15 receipt of
various cancer treatments,16–20 and survival of
cancer (weighted risk ratios consistent with
disadvantage among the uninsured ranged from
1.50 to 10.00).21–26 Cancer care in Canada has
not been without its apparent inequities. For
example, a socioeconomic mammography gra-
dient, albeit much smaller than the US one,
was observed in Canada in the mid-1980s
along with evidence of higher screening rates
among American women.27,28 More recent sam-
ples, however, have demonstrated that federal
and provincial initiatives have substantially re-
duced or eliminated these inequities.29
The fact that the more prevalent screening
participation among American women was not
attendant with earlier stage at diagnosis or sur-
vival advantages underscores the probable
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importance of other prevention strategies such
as the opportunity to develop an ongoing, con-
tinuous relationship with a primary care physi-
cian. Such more generalist life-course preven-
tive interventions probably are more readily
available in Canada, particularly among the
relatively poor. Given that previous studies have
provided substantial adjustments for absolute
income status, race/ethnicity and culture, dif-
ferential longevity, and competing causes of
death and that the consistent pattern of the
Canadian advantage has been observed across
divergent types of cancer (e.g., some associ-
ated with lifestyle, others not), the developing
health insurance theory certainly seems to hold
prima facie validity.
The present analysis tests the health in-
surance hypothesis by means of a systematic
replication of previous Canada (Toronto)–US
cancer survival comparisons with a US met-
ropolitan sample from Hawaii, a state that is
atypical in its history of offering health insur-
ance coverage to its residents. Hawaii has man-
dated employer-based health insurance cover-
age since 1974, and through related legislation
it has also endeavored to insure people em-
ployed part-time as well as those unemployed.
Estimates of Hawaii’s prevalent health insur-
ance coverage have ranged from 89% to 98%
(median estimate=96%).30–34 Such a legisla-
tive mandate has not guaranteed everyone
health insurance, and Hawaii has not been able
to completely eliminate all health status in-
equities (traditional “at-risk” groups [e.g., Na-
tive Hawaiians] and geographic service vari-
abilities still exist). Nevertheless, Hawaii seems
to stand alone among US states in minimizing
the risk of being uninsured. During the mid-
1980s to the mid-1990s, the period during
which the international research on cancer sur-
vival was performed, the prevalence of Hawaii’s
uninsured typically has been half to one quar-
ter that of most other states. We therefore hy-
pothesized that relatively poor Hawaiians would
enjoy a cancer survival experience more sim-
ilar to that of their relatively poor Canadian
counterparts, although we still hypothesized
advantaged survival among Canadians.
Methods
Cancer cases arose from the populations
of greater metropolitan Toronto, Ontario
(Toronto, York, and Peel regions; population
3.5 million in 1991), and Honolulu, Hawaii
(Honolulu County; population 825000 in
1991).35,36 Metropolitan samples were selected
to provide some control for natural health care
service endowment. Physician and hospital-
based preventive, investigative, and therapeu-
tic oncology services, although they may not be
equitably accessible, are well known as the
most available in such areas of Canada and the
United States. The data sources were the On-
tario Cancer Registry (Toronto data) and the
National Cancer Institute’s Surveillance, Epi-
demiology, and End Results (SEER) program
(Honolulu data). Definitions of the study co-
horts were constrained by the following: 1986
was the first year in which the Ontario Cancer
Registry coded the postal code of residence for
most cases, and cohort termination or the date
of last follow-up for both cohorts was De-
cember 31, 1995.37,38 A 5-year survival analy-
sis was based on cumulative incident cases di-
agnosed from 1986 to 1990. Power calculations
based on the between-country comparisons re-
ported in the original Toronto–Detroit study as
well as 3 statistical criteria (2-tailed test; power,
defined as [1– β]=.80; and α=.05 [95% con-
fidence intervals])1,39 determined that there
would be sufficient power to detect meaning-
ful between-country differences for breast and
prostate cancer, the 2 most common types of
cancer for which preventive and therapeutic
interventions are expected to make a differ-
ence. All primary malignant cancers of the
breast among women and of the prostate
among men that occurred in adults (25 years or
older) were included in the analysis (5807
breast and 3383 prostate cancer cases in
Toronto and 1783 breast and 1112 prostate can-
cer cases in Honolulu).
Thepresentanalysis, like theoriginal,used
a census-based SES measure (census tract pro-
portion meeting a “low-income” criterion in
Canada and “poverty” threshold in the United
States) to define relative income quantiles.35,36
Its critical comparisonswere thereforebetween
corresponding income tertiles and deciles in
Toronto and Honolulu. Descriptive profiles of
the resultant income areas that are displayed in
Table 1 demonstrate 2 methodologically im-
portant principles: (1) the construct validity of
this study’s ecologic measures of relative SES
is supported by the clear median income hier-
archies—relatively lowtohigh incomeareas—
observed inbothTorontoandHonolulu, and (2)
even thoughStatisticsCanada’s low-incomecri-
terion is much more liberal than the US Census
Bureau’s poverty threshold, the corresponding
Toronto–Honolulu relative income areas are
strikingly similar in terms of their typical in-
comes (and population sizes and areas; see
Table1 footnotesaandb),providingsubstantial
ecologic control for absolute economic status.
This study’s Honolulu cohort was nearly iden-
tical to the original Toronto and other US co-
horts on data quality indicators: 97.5% of their
residences (census tracts) at the time of diagno-
sis were coded, 95.9% of the cancers were mi-
croscopically confirmed, and 0.8% were enu-
meratedonthebasisofdeathcertificatesonly.37,38
Analytically, the present study’s 5-year
survival analysis was a near-exact replicate of
the original. Survival rates were directly age
adjusted on the basis of this study’s combined
Toronto–Honolulu population of cases by each
specific cancer site across the following age
strata: 25–44, 45–54, 55–64, 65–74, and 75
years or older. Among all the breast and
prostate cancer cases in which the patient was
dead at follow-up, 79% and 63%, respectively,
of the patients died as a direct result of cancer.
Among the sample of cases diagnosed before
65 years of age, however, nearly all subsequent
deaths were attributable to cancer (90% and
81%, respectively). Cancer survival compar-
isons across specific income area strata were
then performed, so that SRRs were greater than
1.00 if Toronto residents were advantaged and
less than 1.00 if Honolulu residents were ad-
vantaged. Ninety-five-percent confidence in-
tervals around survival rate ratios were based
on the Mantel-Haenszel χ2 test.40,41 Through-
out the text, when referring to SRR point esti-
mates that “approached statistical significance,”
we specifically mean that although their asso-
ciated 95% confidence intervals intersected
the null (not significant at α=.05), their cor-
responding 90% confidence intervals did not
(significant at α=.10).
Results
This study systematically replicated the
findings of previous Canadian–US cancer sur-
vival analyses across socioeconomic tertiles—
low-, middle-, and high-income areas—in the
following 3 ways (top of Table 2).
1. The Toronto samples of breast and
prostate cancer cases that extended previous
analyses by 2 years continued to demonstrate
no association between SES and cancer sur-
vival, whereas the Honolulu samples did; 5-
year survival rates were significantly lower in
Honolulu’s relatively low-income areas (breast
and prostate cancer low-income vs high-income
SRRs were 0.94 and 0.85, respectively).
2. The 2 countries’samples did not differ
significantly on cancer survival in the middle-
or high-income groups.
3. As hypothesized for low-income
groups, significantly advantageous survival in
Toronto was observed for both breast cancer
(SRR=1.06) and prostate cancer (SRR=1.10).
Also as hypothesized, the Toronto advantage
was much smaller than had been observed with
its previous comparison with Detroit; the cor-
responding Toronto–Detroit breast and prostate
SRRs were 1.30 and 1.21.1
Consistent with a health insurance expla-
nation for the observed SES–cancer survival
associations in the United States, along with
the observed survival advantages among Cana-
dians who live in relatively low-income areas
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TABLE 1—Descriptive Profiles of Census Tract–Based Income Areas in Toronto, Ontario (1991), and Honolulu, Hawaii (1990)
Toronto, Ontarioa Honolulu, Hawaiib
Low-Income Prevalence Poverty Prevalence
Income Group Range Median Income ($)c Range Median Income ($)c
Income tertiles
Highest
1 1.30–9.40 5.63 56639 0.00–3.29 1.97 57965
2 9.41–17.14 11.69 43315 3.30–7.89 5.38 42780
3 17.15–66.75 22.65 30377 7.90–68.65 16.70 30012
Lowest
Income deciles
Highest
1 1.30–5.09 3.75 58741 0.00–1.59 0.81 61384
2 5.10–6.99 5.95 57161 1.60–2.29 1.90 59130
3 7.00–8.99 7.60 54389 2.30–2.99 2.69 54798
4 9.00–10.89 9.55 49886 3.00–3.89 3.28 52380
5 10.90–12.49 11.50 47117 3.90–5.29 4.80 43502
6 12.50–15.09 13.51 42276 5.30–6.79 6.02 39280
7 15.10–18.39 16.32 39628 6.80–8.59 7.44 38144
8 18.40–22.69 20.19 34337 8.60–10.79 9.53 32690
9 22.70–27.69 25.00 32010 10.80–17.49 13.90 30979
10 27.70–66.75 32.10 25090 17.50–68.65 24.42 21420
Lowest
aPopulation of 3498768 in 1991: 728 census tracts with a mean population of 4806 (SD=1825) and a median population of 4742. Excluding
the small number of outlying tracts (2.6% of 50 km2 or larger), census tracts typically had areas of 1 km2 or less (40%) and a median area of
1.15 km2 (mean=2.53, SD=4.84).
bPopulation of 824600 in 1990: 190 census tracts with a mean population of 4340 (SD=2074) and a median population of 4200. Excluding the
small number of outlying tracts (5.3% of 50 km2 or larger), census tracts typically had areas of 1 km2 or less (45%) and a median area of
1.25 km2 (mean=3.61, SD=5.70).
cCensus tract median annual household income in US dollars.
compared with their US counterparts, most
such associations were larger when the analy-
sis was restricted to patients diagnosed before
the age of 65 years who were not yet eligible
for Medicare coverage in the United States
(bottom of Table 2). Among these younger
breast cancer cohorts, which made up 61% of
this study’s sample of women with breast can-
cer, the low-income vs high-income SRR in
Honolulu was 0.88 (the middle-income vs
high-income SRR approached statistical sig-
nificance [0.93]). Among low-income groups,
even better survival was observed in Toronto vs
Honolulu (SRR=1.12) than had been observed
among the breast cancer cases involving pa-
tients of all ages. None of the within-country
or between-country breast cancer survival com-
parisons were significant among the sample
of women 65 years or older (not shown in
Table 2). As for the younger prostate cancer
cohorts, which made up only 18% of the sam-
ple of men with prostate cancer, a remarkably
similar pattern of within- and between-country
disadvantage among Honolulu’s relatively poor
was observed, although it was generally char-
acterized by point estimates that approached
statistical significance and nonsignificant
trends. Unlike older women with breast cancer,
older prostate cancer patients in relatively low-
income areas remained disadvantaged regard-
ing 5-year cancer survival compared with their
counterparts in relatively high-income areas
(SRR=0.87; 95% confidence interval [95%
CI]=0.77, 0.99).
We then expanded these analyses across
income decile groups to characterize cancer
survival differences across more diverse so-
cioeconomic areas, from the categorically most
affluent to the most impoverished underclass
neighborhoods (Table 3). The following 3 pat-
terns, of interest with regard to health care pol-
icy, emerged from this systematic replication.
1. Even with greatly expanded socioeco-
nomic variability across 10 income areas, no as-
sociationwasobservedbetweenSESandcancer
survival in the Canadian sample; the stark simi-
larity of breast and prostate cancer survival in
Toronto was maintained, even when the lowest-
income decile was compared with the highest.
2. The poorest US income areas were ex-
tremely disadvantaged compared with the most
affluent ones; 5-year survival rates were sig-
nificantly lower in Honolulu’s lowest-income
areas (breast and prostate cancer lowest-income
vs highest-income decile SRRs were 0.78 and
0.69, respectively). Among the Honolulu sam-
ple of women younger than 65 years with breast
cancer, the socioeconomic survival gradient
was even larger (lowest-income vs highest-
income decile SRR=0.69; 95% CI=0.52, 0.91;
not shown in Table 3).
3. Consistent with previous tertile-based
analyses, significantly advantageous survival
among the lowest-income groups in Toronto
was observed for both breast cancer (SRR=
1.20) and prostate cancer (SRR=1.24).Among
women younger than 65 years with breast can-
cer, the estimate of advantaged Canadian sur-
vival was even greater (SRR=1.28; 95% CI=
1.07, 1.53; not shown in Table 3).
It is also important to note that a pattern
of diminished survival typically approaching
statistical significance was observed among
Honolulu’s breast and prostate cancer patients
who lived in Honolulu’s fifth through eighth
income deciles, which may be categorically
defined as representing middle-class to lower-
middle- or working-class neighborhoods
(SRRs ranged from 0.80 to 0.90). Relatedly,
in the sixth decile, fewer such middle-income
women with breast cancer survived for 5 years
than did their Canadian counterparts (SRR=
1.10). Finally, the Toronto–Honolulu breast
cancer (SRR=0.91) and prostate cancer (SRR=
0.89) SRR estimates that approached statisti-
cal significance and were nonsignificant, re-
spectively, suggested that among the most eco-
nomically resourceful cancer patients who live
in the wealthiest 10% of North American
neighborhoods, Americans may enjoy a sur-
vival advantage.
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TABLE 2—Association of Income Tertiles With Breast and Prostate Cancer 5-Year Survival:Toronto, Ontario, and Honolulu,
Hawaii
Cancer Site (ICD-9 Code) Toronto, Ontario Honolulu, Hawaii Toronto/Honolulu Cases
and Income Group n SR SRRa (95% CI)b n SR SRRa (95% CI)b SRRa (95% CI)b
All adult cancer cases
Breast (174)
High 2350 .710 1.00 . . . 595 .728 1.00 . . . 0.98 (0.94, 1.03)
Middle 1582 .716 1.01 (0.97, 1.06) 613 .699 0.96 (0.89, 1.03) 1.02 (0.97, 1.07)
Low 1875 .724 1.02 (0.98, 1.06) 575 .684 0.94 (0.88, 1.00) 1.06 (1.00, 1.12)
Prostate (185)
High 1413 .579 1.00 . . . 327 .605 1.00 . . . 0.96 (0.88, 1.05)
Middle 927 .555 0.95 (0.87, 1.03) 373 .557 0.92 (0.81, 1.05) 1.00 (0.93, 1.07)
Low 1043 .569 0.98 (0.91, 1.06) 412 .517 0.85 (0.74, 0.97) 1.10 (1.00, 1.22)
Adult cancer case patients younger than 65 y
Breast (174)
High 1432 .760 1.00 . . . 418 .785 1.00 . . . 0.97 (0.92, 1.03)
Middle 940 .749 0.99 (0.96, 1.02) 378 .731 0.93 (0.86, 1.01)c 1.02 (0.96, 1.08)
Low 1110 .771 1.01 (0.98, 1.04) 360 .689 0.88 (0.81, 0.96) 1.12 (1.04, 1.20)
Prostate (185)
High 263 .736 1.00 . . . 60 .749 1.00 . . . 0.98 (0.80, 1.20)
Middle 173 .730 0.99 (0.91, 1.08) 63 .684 0.91 (0.73, 1.13) 1.07 (0.88, 1.30)
Low 207 .698 0.95 (0.86, 1.05) 43 .614 0.82 (0.64, 1.05)c 1.14 (0.92, 1.41)
Note. ICD-9= International Classification of Diseases, Ninth Revision; n=number of cumulative incident cancer cases; SR=cumulative survival
rate; SRR=survival rate ratio; CI=confidence interval. Within- and between-country comparisons among adult cancer case patients 65 years
or older are excluded from the table because all except 1 of them (reported in the text) were not minimally statistically significant. Because
statistical power is clearly insufficient to detect meaningful between-country differences among relatively young men with prostate cancer,
this exploratory subanalysis ought to be interpreted with extreme caution until it is either confirmed or refuted with larger samples.
aA survival rate ratio of 1.00 is the baseline.
bConfidence intervals are based on the Mantel-Haenszel χ2 test.
cApproached statistical significance: 90% confidence interval does not intersect the null value of 1.00.
Discussion
We studied the effect of SES on survival
frombreast andprostatecanceramong theadult
populations ofToronto, Ontario, and Honolulu,
Hawaii. In within-country comparisons, breast
and prostate cancer survival in Honolulu was
significantly poorer (on the basis of 95% con-
fidence interval) among people from lower so-
cioeconomic areas. These SES–survival asso-
ciations were larger for steeper socioeconomic
gradients (incomedecilesvs tertiles)andamong
younger breast cancer patients (younger than
65 years) not yet eligible for Medicare partici-
pation.Nosuchassociationswere foundamong
Toronto’s population. In the between-country
analysis that compared cases arising from
TorontoandHonolulu’s low-incomeareas (low-
est third and lowest tenth), we found a consis-
tently significant survival advantage inToronto
that was, again, even larger among younger
breast cancer patients. Furthermore, we found
more tentative evidence of a smaller survival
advantage in Toronto among some categorical
middle-class patients and a concomitant ad-
vantage in the United States amongsomeupper-
class patients.
This pattern of findings points toward the
different health care systems in Canada and
the United States (single-payer vs multipayer)
as its most cogent explanation. Because of
Hawaii’s more prevalent health insurance cov-
erage, we predicted (correctly) that it would
have a cancer survival experience more simi-
lar to a that of a Canadian sample than US sam-
ples in previous Canadian–US comparative
studies had. This study’s general pattern of re-
sults, along with its somewhat attenuated ob-
served associations, substantiates the health in-
surance hypothesis as an explanation for
Canadian–US differences on cancer survival,
particularly among the relatively poor but also
among middle-class and more affluent cancer
patients.
Among the poor, this study’s findings are
consistent with the well-known strong associ-
ations of health insurance status—no insur-
ance or underinsured vs some or adequate cov-
erage—with SES in the United States.42
Notwithstanding questions about the relative
effectiveness of Medicaid, America’s health
care program for the poor, this study’s rela-
tively poor areas contained almost 2 “near-
poor” people (up to 200% of the federally es-
tablished poverty criterion) for each of their
poor residents. Many such marginally impov-
erished people, while generally not meeting
Medicaid’s means test, probably have difficulty
purchasing private health insurance. As for this
study’s middle-class or working-class neigh-
borhoods, these also include significant en-
claves of the near poor (2-fold to 3-fold more
prevalent than the poor in this study’s US sam-
ple), including the working poor as well as
better-off working people who, for a number of
social structural and economic reasons, remain
uninsured or underinsured.42 The tentative ev-
idence that American cancer survival advan-
tage is enjoyed by only a very select few—that
is, the most affluent 10% of the population—
only serves to further indict the American
health care system. It seems to suggest that
only the most fortunate, generally well-insured
people with ample disposable incomes can ex-
pect the best that the US health care system
has to offer.
Hawaii’s pattern of cancer survival, which
is more similar to that of Canada, and its
smaller SES–cancer survival gradients are dif-
ferent from what has been observed in other
states (California, Connecticut, Michigan, and
Washington).1–3 These findings are certainly
consistent with Hawaii’s much greater preva-
lence of health insurance coverage; they are
also consistent with secular trends within
Hawaii. Whereas others have recently found
no association between SES and breast cancer
survival in Hawaii, the gradient most typical
of other states (lower survival rates among the
poor) was observed there in earlier cohorts
from the 1960s through 1970s.43,44 The previ-
ously observed pattern of advantaged Hawai-
ian cancer survival within the United States is
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TABLE 3—Association of Income Deciles With Breast and Prostate Cancer 5-Year Survival: Toronto, Ontario, and
Honolulu, Hawaii
Toronto, Ontario Honolulu, Hawaii Toronto/Honolulu Cases
Income Group n SR SRRa (95% CI)b n SR SRRa (95% CI)b SRRa (95% CI)b
Breast cancer
Highest
1 685 .705 1.00 . . . 120 .774 1.00 . . . 0.91 (0.81, 1.02)c
2 777 .711 1.01 (0.93, 1.10) 272 .730 0.94 (0.82, 1.07) 0.97 (0.89, 1.06)
3 737 .713 1.01 (0.95, 1.08) 157 .717 0.93 (0.81, 1.06) 0.99 (0.89, 1.10)
4 472 .726 1.03 (0.96, 1.11) 147 .751 0.97 (0.86, 1.09) 0.97 (0.87, 1.08)
5 488 .734 1.04 (0.97, 1.12) 192 .723 0.93 (0.81, 1.07) 1.02 (0.87, 1.19)
6 453 .682 0.97 (0.90, 1.04) 186 .620 0.80 (0.69, 0.93) 1.10 (0.98, 1.23)c
7 422 .708 1.00 (0.81, 1.24) 177 .697 0.90 (0.79, 1.02)c 1.02 (0.91, 1.15)
8 597 .724 1.03 (0.95, 1.11) 223 .750 0.97 (0.87, 1.09) 0.97 (0.89, 1.05)
9 457 .743 1.05 (0.98, 1.13) 157 .704 0.91 (0.80, 1.04) 1.06 (0.95, 1.18)
10 719 .718 1.02 (0.95, 1.10) 152 .600 0.78 (0.67, 0.91) 1.20 (1.06, 1.36)
Lowest
Prostate cancer
Highest
1 432 .568 1.00 . . . 80 .638 1.00 . . . 0.89 (0.73, 1.08)
2 423 .595 1.05 (0.94, 1.18) 125 .644 1.01 (0.67, 1.51) 0.92 (0.79, 1.07)
3 457 .580 1.02 (0.92, 1.13) 103 .569 0.89 (0.69, 1.14) 1.02 (0.76, 1.36)
4 293 .576 1.01 (0.94, 1.09) 90 .579 0.91 (0.72, 1.15) 0.99 (0.75, 1.31)
5 278 .525 0.92 (0.79, 1.07) 130 .508 0.80 (0.63, 1.02)c 1.03 (0.86, 1.23)
6 282 .556 0.98 (0.85, 1.13) 94 .585 0.92 (0.73, 1.16) 0.95 (0.77, 1.17)
7 243 .569 1.00 (0.80, 1.26) 117 .527 0.83 (0.65, 1.06) 1.08 (0.90, 1.29)
8 325 .570 1.00 (0.91, 1.10) 160 .523 0.82 (0.66, 1.03)c 1.09 (0.93, 1.28)
9 252 .560 0.99 (0.93, 1.05) 110 .580 0.91 (0.72, 1.15) 0.97 (0.83. 1.13)
10 398 .547 0.96 (0.83, 1.11) 103 .440 0.69 (0.53, 0.90) 1.24 (1.01, 1.53)
Lowest
Note. ICD-9= International Classification of Diseases, Ninth Revision; n=number of cumulative incident cancer cases; SR=cumulative survival
rate; SRR=survival rate ratio; CI=confidence interval.
aA survival rate ratio of 1.00 is the baseline.
bConfidence intervals are based on the Mantel-Haenszel χ2 test.
cApproached statistical significance: 90% confidence interval does not intersect the null value of 1.00.
also consistent with this study’s findings.45 It is
possible—but, we think, improbable—that
other factors may account for this study’s find-
ings. In addition to its unique health insurance
system, Hawaii also has a relatively unique eth-
nic distribution and at least the suggestion of a
significantly different lifestyle than elsewhere.
As elsewhere, race/ethnicity and lifestyle
factors such as diet and smoking have been ob-
served to be associated with the occurrence and
prognosis of some cancers,46–55 although the ef-
fects, particularly for survival, may generally be
categorized as very small. The majority of can-
cer case patients we studied in Honolulu were
Asian Americans or Pacific Islanders (63%);
most of the others wereWhite (32%).37,38 It was
notpossible tomathematicallyadjust for thisfac-
tor, as theOntarioCancerRegistrydoesnot rou-
tinelycoderace/ethnicity.However,wedidrepli-
cate the between-country comparisons with the
non-White and White Honolulu cohorts. Al-
though there were some power problems, these
analyses did not result in any practical alteration
of our findings. We think that the ethnicity/
lifestyle hypotheses are not particularly potent
alternative explanations, for a number of other
reasons.
1. The findings within Hawaii were as di-
vergent from those of other states, as were the
between-country ones.
2. Asian Americans and Pacific Islanders
are by no means a homogeneous group of
people. In fact, evidence suggests that re-
garding breast cancer survival among Hawai-
ian residents, for example, Native Hawaiian,
Filipino, and Chinese people may be disad-
vantaged relative to Whites, while Japanese
people are advantaged.49
3. Toronto may also be generally charac-
terized as a multicultural population, although
not to the same degree as Honolulu. Approxi-
mately a third of Toronto’s residents are people
of color, and nearly one quarter of them emi-
grated during the past 10 years.35
4. The so-called Hawaiian lifestyle
seems to be based more in mythology than
empiricism. The prevalence of actual relevant
risky behaviors (lack of exercise, overweight,
smoking, and excessive alcohol consump-
tion) among Hawaiians has been observed to
be strikingly similar to that of most other
states.56 Therefore, whatever influences eth-
nicity and lifestyle impart in such survival
analyses, they are not likely to be systematic,
and so they are not likely to confound this
study’s findings.
In fact, we believe that if there is any
bias in this study’s Canada–US comparative
analyses of low-income groups, it is prob-
ably that its SRR point estimates are un-
derestimates of the truth, for the following
reasons.
1. Whereas both female life expectancy
and male life expectancy at birth are more
than 2 years greater in Canada than in the
United States, these figures are more than 3
years greater for Honolulu than for
Toronto.57–60
2. Any information bias due to ecologic
measurement of SES is likely to be similarly
nondifferential among this study’s Canadian
and US samples1–3,5,61–70; relatedly, owing to
this study’s focus on 10 socioeconomic areas
(in Honolulu, median household incomes in
these areas in 1990 ranged from $21420 to
$61384), actual socioeconomic variability, and
therefore the ability to detect meaningful ef-
fects, was substantially diminished (Honolulu
median incomes across its 190 census tracts
ranged from $5000 to $149850).
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3. In focusing on all-cause rather than
cancer-specific censored survival, this study
used a more conservative analytic approach,
in that cancer-specific death rates may under-
estimate the mortality associated with a diag-
nosis of cancer.71 Recall also that cancer was
the underlying cause of the vast majority of
deaths, particularly among the younger cohort
not eligible for Medicare. Moreover, the un-
derlying cause of the majority of “noncancer”
deaths—respiratory and circulatory prob-
lems—can often be directly associated with
the treatment of cancer or, for that matter, with
its nontreatment. We therefore believe that this
study’s findings are best characterized as con-
servative estimates of Canadian–US cancer
outcome differences.
Conclusions
This study’s central finding of advantaged
Canadian vs American cancer survival, par-
ticularly among relatively low-income groups,
implicates health care systemic factors as its
most cogent explanation. Although Hawaii’s
prevalent health insurance coverage does seem
attendant with better management of cancer
care than that of other states, people with can-
cer in Toronto still enjoy a significant survival
advantage. Employer-mandated health insur-
ance coverage certainly seems to be a large
step toward providing more equitable health
care. However, this study provides evidence to
suggest that even better care could be expected
among more Americans through movement to
a more universally accessible, single-payer sys-
tem such as Canada’s.
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